Filing Details
SkinHealth Systems Inc. (NASDAQ:SKIN) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 12, 2026.
The Consumer Defensive company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Market Context
SkinHealth Systems Inc.'s stock currently trades at $0.65 with a market capitalization of $185.5M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing SkinHealth Systems Inc.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for SkinHealth Systems Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SKIN Stock Page
Frequently Asked Questions
Where can I read SKIN's SEC filings?
Browse all filings on our SKIN SEC filings page.
What types of SEC filings does SkinHealth Systems Inc. file?
Public companies like SkinHealth Systems Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.